Meet The Team

The EMTHERA Faculty is composed of more than 100 scientists from Goethe University Frankfurt (GU), Johannes Gutenberg University Mainz (JGU), from several Max Planck Institutes, the Fraunhofer Institute for Translational Medicine and Pharmacology (Fraunhofer-ITMP), the Frankfurt Institute for Advanced Studies (FIAS), the Helmholtz Institute for Translational Oncology (HI-TRON), the Institute of Molecular Biology gGmbH (IMB), the Leibniz Institute for Resilience Research (LIR) and from Translational Oncology at University Medical Center Mainz gGmbH (TRON).

We are proud to be highly interdisciplinary within the EMTHERA faculty, covering a broad expertise from computational to natural sciences, clinical medicine and the financial sector. Within the EMTHERA faculty, the Junior Academy clusters all early career researchers and offers many activities, e.g. a lectures series on AI in Life Sciences. If your are based in the Rhine-Main region, interested in our research and wishing to join, please contact the project office.

The Steering Committee is composed of six scientists from Frankfurt and Mainz who together have taken the lead in establishing the network. A Scientific Advisory Board has been set up with internationally renowned experts from the fields. An overview of the governance structure can be found below.

Steering Commtte

Steering committee

Tobias Bopp

Immunology, JGU Mainz

„For me, EMTHERA provides the unique opportunity to work together with excellent scientists in an interdisciplinary fashion on tomorrow's therapies for diseases that are currently incurable.“

Wolfram Ruf

Thrombosis & Hemostasis, IMB & JGU Mainz

„EMTHERA provides tremendous opportunities to leverage excellent expertise and productive synergies in the development of innovative therapeutics addressing the most challenging clinical problems in chronic inflammatory diseases.“

Sandra Ciesek

Virology, GU Frankfurt

„The COVID pandemic has revealed our vulnerability towards emerging pathogens and underlines the severe impact of immune and inflammatory responses on outcome of diseases. EMTHERA helps us to better understand these interfaces.“

Özlem Türeci

Immunotherapy, JGU Mainz

„We will multiply the power of science by working together, and contribute to solving most pressing biomedical challenges. The success of mRNA-based COVID vaccines proves how platform technologies can be smartly employed to achieve the impossible.“

Ivan Đikić

Cell & Molecular Biology, GU Frankfurt

„Enabled by novel tools and technologies, EMTHERA will tackle some of the most challenging biomedical questions. At the same time, it provides the unique opportunity to educate the next generation of truly interdisciplinary scientists.“

Maike Windbergs

Pharmaceutical Technology, GU Frankfurt

„EMTHERA builds a perfect bridge between basic and translational sciences. A better understanding of molecular mechanisms will lead to discovery of novel targets and unique therapeutic strategies, thereby speeding up translation."

SAB

Scientific Advisory Board